Coverage Policies
Blue Cross Blue Shield of Alabama
Molecular Markers in Fine Needle Aspirates of the Thyroid
Cigna
Tumor Profiling, Gene Expression Assays and Molecular Diagnostic Testing for Hematology/Oncology Indications
UHC Oxford
Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions
ThyGeNEXT® and ThyraMIR® have been reviewed by the BlueCross BlueShield Association’s Evidence Street which found that clinical input from specialty societies and physicians at academic centers support use for individuals with nodule(s) with an indeterminate FNA finding…[testing] would provide a clinical meaningful improvement in net health outcome.
–From Medical Policy 2.04.78, Molecular Markers in Fine Needle Aspiration of the Thyroid
